DE19675017I2 - Neue Derivate der 3-Aminopropansulfonsaeure diese enthaltende Arzneimittel sowie Verfahren zu ihrer Herstellung - Google Patents

Neue Derivate der 3-Aminopropansulfonsaeure diese enthaltende Arzneimittel sowie Verfahren zu ihrer Herstellung

Info

Publication number
DE19675017I2
DE19675017I2 DE1996175017 DE19675017C DE19675017I2 DE 19675017 I2 DE19675017 I2 DE 19675017I2 DE 1996175017 DE1996175017 DE 1996175017 DE 19675017 C DE19675017 C DE 19675017C DE 19675017 I2 DE19675017 I2 DE 19675017I2
Authority
DE
Germany
Prior art keywords
processes
preparation
acid containing
new derivatives
aminopropanesulfonic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE1996175017
Other languages
English (en)
Inventor
Jean-Pierre Durlach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sante SAS
Original Assignee
LIPHA SAS
LIPHA Liyonnaise Industrielle Pharmaceutique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIPHA SAS, LIPHA Liyonnaise Industrielle Pharmaceutique filed Critical LIPHA SAS
Application granted granted Critical
Publication of DE19675017I2 publication Critical patent/DE19675017I2/de
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • C07C309/15—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton the nitrogen atom of at least one of the amino groups being part of any of the groups, X being a hetero atom, Y being any atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
DE1996175017 1979-05-23 1980-05-21 Neue Derivate der 3-Aminopropansulfonsaeure diese enthaltende Arzneimittel sowie Verfahren zu ihrer Herstellung Active DE19675017I2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7913207A FR2457281A1 (fr) 1979-05-23 1979-05-23 Nouveaux derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee

Publications (1)

Publication Number Publication Date
DE19675017I2 true DE19675017I2 (de) 2001-04-26

Family

ID=9225819

Family Applications (2)

Application Number Title Priority Date Filing Date
DE1996175017 Active DE19675017I2 (de) 1979-05-23 1980-05-21 Neue Derivate der 3-Aminopropansulfonsaeure diese enthaltende Arzneimittel sowie Verfahren zu ihrer Herstellung
DE19803019350 Granted DE3019350A1 (de) 1979-05-23 1980-05-21 Neue derivate der 3-aminopropansulfonsaeure mit verstaerkten membranstabilisierenden eigenschaften

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19803019350 Granted DE3019350A1 (de) 1979-05-23 1980-05-21 Neue derivate der 3-aminopropansulfonsaeure mit verstaerkten membranstabilisierenden eigenschaften

Country Status (18)

Country Link
US (1) US4355043A (de)
JP (2) JPS5625146A (de)
AT (1) AT372371B (de)
AU (1) AU535785B2 (de)
BE (1) BE883468A (de)
CA (1) CA1152100A (de)
CH (1) CH647757A5 (de)
DE (2) DE19675017I2 (de)
ES (1) ES491787A0 (de)
FR (1) FR2457281A1 (de)
GB (1) GB2051789B (de)
GR (1) GR68547B (de)
IT (1) IT1130455B (de)
MA (1) MA18855A1 (de)
MX (1) MX9203363A (de)
NL (2) NL191789C (de)
OA (1) OA06606A (de)
ZA (1) ZA803051B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU193197B (en) * 1984-02-03 1987-08-28 Egyt Gyogyszervegyeszeti Gyar Preparatives regulating the growth of plants containing as reagent derivatives of n-substituated amin-prophansulphonic acid and process for production of the reagent
JPH0725771B2 (ja) * 1992-06-18 1995-03-22 財団法人生産開発科学研究所 ２−アミノエタンスルホン酸亜鉛錯化合物
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
AU703540B2 (en) * 1996-03-26 1999-03-25 Meddiss, Incorporated Methods for inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
US6057373A (en) * 1997-05-22 2000-05-02 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists
US6391922B1 (en) 1998-01-13 2002-05-21 Synchroneuron, Llc Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders
CN1293573A (zh) * 1998-01-13 2001-05-02 同步神经元有限责任公司 迟发性运动障碍和其它运动疾病的治疗方法
US5952389A (en) * 1998-01-13 1999-09-14 Synchroneuron Methods of treating tardive dyskinesia and other movement disorders
US6294583B1 (en) * 1998-01-13 2001-09-25 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders
ATE251129T1 (de) * 1998-01-27 2003-10-15 Merck Sante Sas Derivatives of aminoalkane sulphonic, phosphonic and phosphinic acids, their preparation and their use as medicaments
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
ATE441421T1 (de) * 1999-04-28 2009-09-15 Bellus Health Int Ltd Zusammensetzungen und verfahren zur behandlung von amyloidosis mit sulphonatderivaten
US6562836B1 (en) 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
BRPI0517790A (pt) * 2004-11-12 2008-10-21 Neurochem Int Ltd métodos e composições fluoradas para tratar doenças relacionadas à amilóide
CN101103018A (zh) * 2004-11-16 2008-01-09 神经化学（国际）有限公司 治疗cns和淀粉样蛋白-相关疾病的化合物
CA2592320C (en) * 2004-12-22 2015-11-24 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
DE602006016990D1 (de) * 2005-12-22 2010-10-28 Bellus Health Int Ltd Behandlung von diabetischer nephropathie
EP2862581B1 (de) 2006-10-12 2021-08-11 BHI Limited Partnership Verfahren, Verbindungen, Zusammensetzungen und Medien zur Abgabe von 3-Amino-1-Propanesulfonsäure
AU2007337806A1 (en) * 2006-12-22 2008-07-03 Bellus Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
KR100877134B1 (ko) * 2007-05-03 2009-01-09 주식회사 엔지켐 아캄프로세이트 칼슘의 제조방법
WO2009033079A1 (en) * 2007-09-07 2009-03-12 Xenoport, Inc. Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
TW200924748A (en) * 2007-09-07 2009-06-16 Xenoport Inc Masked carboxylate neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
US20090099253A1 (en) * 2007-10-15 2009-04-16 Xenoport, Inc. Internally Masked Neopentyl Sulfonyl Ester Cyclization Release Prodrugs of Acamprosate, Compositions Thereof, and Methods of Use
CN101492400B (zh) * 2008-01-22 2014-03-12 北京华禧联合科技发展有限公司 一种高纯度阿坎酸钙的制备方法
DE102008048791A1 (de) * 2008-09-24 2010-03-25 Merck Patent Gmbh Neue Kristallform von Calcium-3-Acetylaminopropan-1-sulfonat
IT1392327B1 (it) * 2008-09-26 2012-02-28 Laboratorio Chimico Int Spa Nuova forma polimorfa del calcio acamprosato
CN104478766A (zh) * 2014-12-25 2015-04-01 北京华禧联合科技发展有限公司 一种制备高纯度乙酰基高牛磺酸的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3039916A (en) * 1961-03-27 1962-06-19 West Laboratories Inc Anionic iodine complexes
US3544597A (en) * 1969-06-12 1970-12-01 Rohm & Haas Process for manufacturing sulfonated amides
JPS5418714B2 (de) * 1974-10-08 1979-07-10
FR2321285A1 (fr) * 1975-08-18 1977-03-18 Stanley Drug Products Inc Agents antifibrinolytiques
FR2384751A1 (fr) * 1977-03-23 1978-10-20 Francaise Coop Pharma Nouveaux derives de la taurine a activite neuro-musculaire renforcee
US4233229A (en) * 1978-01-03 1980-11-11 Gaf Corporation Preparation of salt-free N-acyl taurines

Also Published As

Publication number Publication date
ATA274580A (de) 1983-02-15
US4355043A (en) 1982-10-19
IT1130455B (it) 1986-06-11
AT372371B (de) 1983-09-26
JPH0317825B2 (de) 1991-03-11
GR68547B (de) 1982-01-18
MA18855A1 (fr) 1980-12-31
AU5869780A (en) 1980-11-27
CH647757A5 (fr) 1985-02-15
BE883468A (fr) 1980-11-24
ES8101042A1 (es) 1980-12-16
JPS5625146A (en) 1981-03-10
DE3019350A1 (de) 1980-12-04
GB2051789A (en) 1981-01-21
NL8002997A (nl) 1980-11-25
ES491787A0 (es) 1980-12-16
NL970003I1 (nl) 1997-04-01
OA06606A (fr) 1981-08-31
NL970003I2 (nl) 1997-08-01
ZA803051B (en) 1981-06-24
GB2051789B (en) 1983-04-27
IT8067807A0 (it) 1980-05-22
JPH03148219A (ja) 1991-06-25
MX9203363A (es) 1992-07-01
JPH0524135B2 (de) 1993-04-06
NL191789B (nl) 1996-04-01
FR2457281A1 (fr) 1980-12-19
FR2457281B1 (de) 1983-10-07
CA1152100A (en) 1983-08-16
AU535785B2 (en) 1984-04-05
DE3019350C2 (de) 1989-11-30
NL191789C (nl) 1996-08-02

Similar Documents

Publication Publication Date Title
DE19675017I2 (de) Neue Derivate der 3-Aminopropansulfonsaeure diese enthaltende Arzneimittel sowie Verfahren zu ihrer Herstellung
PT68771A (de) Neue 9-(omega-heteroarylamino-alkylamino)-erythromycine ihre salze verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE19875010I2 (de) Acetamidderivate Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
PT74080B (de) Neue 8-arylalkyl-3-phenyl-3-nortropanole deren saeureadditions-salze diese enthaltende arzneimittel und verfahren zu ihrer herstellung
IL52280A0 (en) New derivatives of penicillanic acid their preparation and pharmaceutical compositions containing them
PT66637B (en) Process for the preparation of 4-trifluoromethylbenzoic acid derivatives and pharmaceutical compositions containing same
PT69239A (de) Neue substituierte 2-phenylimino-imidazolidine deren saureadditionssalze diese enthaltende arzneimittel und verfahren zur herstellung derselben
ATA292078A (de) Verfahren zur herstellung von neuen 9-amino- desoxyclavulansaeurederivaten
PT66858B (de) 2-benzylpyrrolidine verfahren zu ihrer herstellung und sieenthaltende arzneimittel
PT65121A (de) Neue propargyl-2-phenylamino-imidazoline-(2(,deren saeureadditionssalze,diese enthaltende arzneimittel und verfahren zur herstellung derselben
PT66756B (de) 2-brom-6-fluor-n-2-imidazolidinyliden-benzamin dessen saureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
IL52996A0 (en) New derivatives of 2-(3-phenyl-2-aminopropionyloxy) acetic acid their preparation and pharmaceutical compositions containing them
PT65521B (de) "n-te trahydrofurfuryl-noroxymorphone deren saureadditionssalze diese enthaltende arzneimittel sowie verfahren zu ihrer herstellung
PT68404A (de) 4-hydroxy-2-benzimidazolinon-derivate verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
PT71247A (de) Salze von thiazolyliden-oxo-propionitrilen insektizide mittel enthaltend diese salze sowie verfahren zu ihrer herstellung
PH13924A (en) Glavulanic acid derivatives,pharmaceutical compositions containing same and method of preparation thereof
NZ193107A (en) 1-hydroxy-2-piperazinylethyl derivatives of benzoic acid pharmaceutical compositions
NZ184408A (en) 16-s-acyl derivatives of 16-deacetoxy-fusidic acid and pharmaceutical compositions
IL57939A0 (en) Pharmaceutical compositions containing n-substituted aziridine-2-carboxylic acid derivatives and processes for the preparation of said n-substituted aziridine-2-carboxylic acid derivatives
LU79124A1 (de) Neue arzneimittelkombinationen und verfahren zu ihrer herstellung
PT69156A (de) Neue purin-derivate verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
PT65491B (de) Vinylthionophosphorsaureester verfahren zu ihrer herstellung sowie ihre verwendung als insektizide und akarizide
PT76986B (de) Neue phenylessigsaeure-derivate ihre herstellung und diese verbindungen enthaltende arzneimittel
DK158775C (da) Katalysator og anvendelse af katalysatoren til fremstilling af salpetersyre
JPS5373535A (en) Phthalic acid derivative * method of its preparation and hardening mixture containing said compound